Register for streaming realtime charts, analysis tools, and prices.
Period:
Draw Mode:
| Volume | 138,048 |
|
|||||
| News | - | ||||||
| Day High | 0.3999 | Low High |
|||||
| Day Low | 0.3411 | ||||||
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Mustang Bio Inc | MBIO | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded
|
|
|---|---|---|---|---|
| -0.0131 | -3.53% | 0.3579 | 19:07:03 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 0.3601 | 0.3411 | 0.3999 | 0.3416 | 0.371 |
| Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
|---|---|---|---|---|---|
| 453 | 138,048 | $ 0.3593137 | $ 49,603 | - | 0.33 - 8.17 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 19:00:03 | formt | 598 | $ 0.3579 | USD |
Mustang Bio Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 3.64M | 10.39M | - | 0 | -51.6M | -4.97 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
Mustang Bio News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical MBIO Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 0.5308 | 0.5498 | 0.33 | 0.3835891 | 354,884 | -0.1729 | -32.57% |
| 1 Month | 1.10 | 1.15 | 0.33 | 0.613281 | 270,511 | -0.7421 | -67.46% |
| 3 Months | 1.43 | 1.52 | 0.33 | 1.01 | 212,718 | -1.07 | -74.97% |
| 6 Months | 1.74 | 2.11 | 0.33 | 1.17 | 154,811 | -1.38 | -79.43% |
| 1 Year | 3.85 | 8.17 | 0.33 | 1.95 | 98,008 | -3.49 | -90.70% |
| 3 Years | 45.00 | 60.90 | 0.33 | 26.47 | 640,213 | -44.64 | -99.20% |
| 5 Years | 91.80 | 103.50 | 0.33 | 41.76 | 848,418 | -91.44 | -99.61% |
Mustang Bio Description
| Mustang Bio Inc is a clinical-stage biopharmaceutical company focused on translating today's medical breakthroughs in cell and gene therapy into potential cures for hematologic cancers, solid tumors and rare genetic diseases. Its pipeline is currently focused on the core areas of gene therapies for rare genetic disorders, chimeric antigen receptor (CAR) engineered T cell (CAR T) therapies for hematologic malignancies and CAR T therapies for solid tumors. |
